医薬品容器の世界市場：成長、将来展望、競合分析、2025年～2033年

医薬品容器市場には、医薬品に使用される様々な包装メカニズムが集約されています。これらの容器は、医薬品やその他の製品を湿気、光、酸素などの外的要因から確実に保護し、効能を保ち、保存期間を延長するために不可欠です。製薬業界の急成長に伴い、容器市場も拡大しています。2024年には、成長の原動力から課題まで、無数の要因がこの市場に影響を与えました。医薬品容器市場は、2025年から2033年にかけてCAGR 6.0％で成長すると推定されます。

促進要因：世界の医薬品需要の増加

過去20年間で、糖尿病から心血管疾患に至るまで、慢性疾患が急増しました。例えば、世界保健機関（調査会社エビデンスなし）は、慢性疾患が世界全体の死亡原因の約60％を占めていると指摘しています。この急増は、当然ながら薬の需要の高まりにつながり、その結果、薬を保管する容器の需要も高まります。さらに、COVID-19パンデミックのような新たな健康課題も、この需要を際立たせました。ワクチンや抗ウイルス薬の急速な開発、生産、世界の流通は、大量の医薬品容器を必要としました。そのため、バイアル、アンプル、その他の特殊容器の世界の需要に対応するため、メーカーは生産規模を拡大する必要がありました。

機会：生分解性で持続可能な包装の出現

持続可能性が世界の関心事となる中、あらゆる業界が環境に優しいソリューションへと移行しています。医薬品容器分野もこの変化と無縁ではありません。特にプラスチック汚染に対する世界の声を受けて、企業は生分解性容器の実験や生産を始めています。『サイエンス・アドバンシズ』誌に掲載されたある調査（調査会社エビデンスなし）は、世界のプラスチックの9％しかリサイクルされていないことを浮き彫りにしました。このデータは、持続可能な代替品の必要性を強調し、医薬品容器メーカーに革新を促しました。植物由来のプラスチックやその他の生分解性成分などの素材から作られた新しい容器は、環境問題に対応するだけでなく、製造過程における二酸化炭素排出量の削減などの利点もあります。この移行は、医薬品の封じ込めと環境の持続可能性という二重の需要に対応するため、市場企業に有利な機会を提供します。

抑制要因：厳しい規制遵守

製薬業界は、公衆衛生に直接的な影響を及ぼすことから、厳しい規制を受けており、その規制は容器にも及んでいます。米国食品医薬品局（FDA）や欧州医薬品庁（EMA）のような規制機関は、これらの容器が満たさなければならない明確で、しばしば厳しい基準を概説しています。これらの規制は、容器が保存している医薬品と相互作用し、医薬品の特性を変化させ、患者の安全性を損なう可能性がないことを確認するものです。こうした基準が必要であることは論を待たないが、一方で課題もあります。製造業者は、容器のコンプライアンス確保に多大な投資をすることになり、コストアップにつながることが多いです。さらに、コンプライアンス違反はリコールにつながる可能性があり、製薬会社は経済的・評判的な影響を考えると、このシナリオを恐れています。

課題：偽造医薬品包装

収益性の高い市場と同様に、医薬品容器セグメントも代替品の脅威と闘っています。偽造医薬品は世界の問題であり、偽造者はしばしばオリジナルとよく似たパッケージを使用するため、両者を区別するのは困難です。世界保健機関（WHO）は報告書の中で、世界の医薬品の最大10％が偽造品である可能性があり、深刻な健康リスクをもたらすと述べています。医薬品容器メーカーにとって、この動向は憂慮すべきものです。こうした偽造品による損失に直面するだけでなく、偽薬の存在はブランドに対する信頼も損ないます。これに対抗するためには、改ざん防止シールや一意の識別子といったセキュリティ機能への追加投資が必要となり、コストはさらに増大します。

製品別の洞察

ボトルは、その普遍性と利便性により、歴史的にこの市場を独占してきました。ボトルは2024年に最も高い収益を生み出す枠を占め、かなりの市場シェアを占めています。市販の液体医薬品から無数の処方薬まで幅広い用途が、その優位性を裏付けています。これに続くのがブリスターです。ブリスターは単位用量包装に不可欠であり、湿気からの保護も強化されているため、多くの製薬会社に愛用されています。しかし、CAGRが最も高かったのはプレフィルドシリンジとカートリッジでした。その成長の要因は、ワクチンや生物製剤の需要増にあります。投与が簡単で無駄が少なく、無菌状態を維持できるため、新しいドラッグデリバリーには好ましい選択肢となっています。バイアル＆アンプル、バッグ＆パウチ、サシェ、チューブなどの他の製品も大きな市場シェアを占めており、予測期間中も様々な速度で成長すると予想されます。

材料タイプ別の洞察

プラスチックは、その汎用性と費用対効果により、2024年に最も高い収益を上げました。様々な形状に成形することができ、軽量であることも相まって、医薬品容器として広く選ばれています。不浸透性と透明性で知られるガラスは、売上高ではプラスチックに遅れをとったが、その不活性な性質から特定の医薬品に好まれることが多いです。興味深いことに、特にアルミ製ブリスターパックや特定の軟膏チューブの形をした金属が最も高いCAGRを示しました。その成長は、光、湿気、酸素に対して優れたバリアを提供する能力に関連しています。一方、紙は主に二次包装に使用され、市場に貢献したが、前者の材料に比べるとニッチでした。

地域別の洞察

米国の広大な製薬産業が牽引する北米は、2024年の売上高比率が最も高いです。同地域の強固なヘルスケアインフラと医薬品イノベーションが、同地域を最前線に押し上げました。しかし、2025年から2033年にかけては、インドや中国などのアジア太平洋地域が最も高いCAGRを記録すると予想されています。その理由は、医薬品生産の増加、有利な政府政策、膨大な人口の間でのヘルスケア意識の高まりです。

競合動向

2024年の医薬品容器市場には、いくつかの有力企業が点在しています。Amcor Plc、Ardagh Group S.A.、Becton, Dickinson and Company、Berry Global Group, Inc.、Bilcare Limited、Catalent, Inc.、Clondalkin Group Holdings B.V.、Constantia Flexibles Group GmbH、Gerresheimer AG、Klockner Pentaplast Group、Mondi Group、Nipro Corporation、Piramal Glass Private Limited、Schott AG、Sealed Air Corporation、Uflex Ltd.、West Pharmaceutical Services, Inc、West Pharmaceutical Services, Inc.、Westrock Company、Wipak Group、Harpak Ulma、Bandall Pharma Packaging Solutions、Nolato AB（publ）、Medical Packaging Inc.などの企業はイノベーションと持続可能なソリューションに注力し、収益創出を主導しました。これらの企業の戦略は、M&A、生産能力の拡大、斬新で患者に優しいパッケージングソリューションの導入に重点が置かれていることが多いです。持続可能性が世界のキーワードになるにつれ、これらの企業の多くは環境に優しいパッケージングオプションにシフトしました。改ざん防止シール、RFIDチップを搭載したスマート包装ソリューション、アドヒアランスモニタリング機能などのイノベーションは、予測期間中、これらの市場企業の戦略の焦点になると予想されます。2025年が近づくにつれ、技術競争とイノベーション主導の市場競争が激化し、各企業は技術と持続可能性を駆使して首位の座を争うと予想されます。

目次

第1章 序文

• レポート内容
  • レポートの目的
  • 対象者
  • 主な提供
• 市場セグメンテーション
• 調査手法
  • フェーズⅠ - 二次調査
  • フェーズⅡ - 一次調査
  • フェーズⅢ - 有識者レビュー
  • 前提条件
  • 採用したアプローチ

第2章 エグゼクティブサマリー

第3章 医薬品容器市場：競合分析

• 主要ベンダーの市場ポジショニング
• ベンダーが採用した戦略
• 主要な産業戦略

第4章 医薬品容器市場：マクロ分析と市場力学

• イントロダクション
• 世界の医薬品容器市場価値（2023年～2033年）
• 市場力学
  • 市場促進要因
  • 市場抑制要因
  • 主な課題
  • 主な機会
• 促進要因と抑制要因の影響分析
• シーソー分析
• ポーターのファイブフォースモデル
  • サプライヤーパワー
  • バイヤーパワー
  • 代替品の脅威
  • 新規参入業者の脅威
  • 競争企業間の敵対関係
• PESTEL分析
  • 政治情勢
  • 経済情勢
  • 技術情勢
  • 法的情勢
  • 社会情勢

第5章 医薬品容器市場：製品別（2023年～2033年）

• 市場概要
• 成長・収益分析：2024年 vs 2033年
• 市場セグメンテーション
  • ボトル
    • パッカーボトル
    • 液体ボトル
  • バイアルとアンプル
  • ブリスター
  • バッグ・パウチ
  • プレフィルドシリンジとカートリッジ
  • サシェ
  • トレイ
  • チューブ
  • 容器瓶・その他

第6章 医薬品容器市場：材料タイプ別（2023年～2033年）

• 市場概要
• 成長・収益分析：2024年 vs 2033年
• 市場セグメンテーション
  • プラスチック
    • ポリエチレン
    • ポリ塩化ビニル
    • ポリプロピレン
    • ポリスチレン
    • ポリエチレンテレフタレート
    • その他（ポリカーボネート）
  • ガラス
  • 金属
  • 紙

第7章 北米の医薬品容器市場（2023年～2033年）

• 市場概要
• 医薬品容器市場：製品別（2023年～2033年）
• 医薬品容器市場：材料タイプ別（2023年～2033年）
• 医薬品容器市場：地域別（2023年～2033年）
  • 北米
    • 米国
    • カナダ
    • その他北米

第8章 英国と欧州連合の医薬品容器市場（2023年～2033年）

• 市場概要
• 医薬品容器市場：製品別（2023年～2033年）
• 医薬品容器市場：材料タイプ別（2023年～2033年）
• 医薬品容器市場：地域別（2023年～2033年）
  • 英国と欧州連合
    • 英国
    • ドイツ
    • スペイン
    • イタリア
    • フランス
    • その他欧州

第9章 アジア太平洋の医薬品容器市場（2023年～2033年）

• 市場概要
• 医薬品容器市場：製品別（2023年～2033年）
• 医薬品容器市場：材料タイプ別（2023年～2033年）
• 医薬品容器市場：地域別（2023年～2033年）
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他アジア太平洋

第10章 ラテンアメリカの医薬品容器市場（2023年～2033年）

• 市場概要
• 医薬品容器市場：製品別（2023年～2033年）
• 医薬品容器市場：材料タイプ別（2023年～2033年）
• 医薬品容器市場：地域別（2023年～2033年）
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ

第11章 中東・アフリカの医薬品容器市場（2023年～2033年）

• 市場概要
• 医薬品容器市場：製品別（2023年～2033年）
• 医薬品容器市場：材料タイプ別（2023年～2033年）
• 医薬品容器市場：地域別（2023年～2033年）
  • 中東・アフリカ
    • GCC
    • アフリカ
    • その他中東・アフリカ

第12章 企業プロファイル

• Amcor Plc
• Ardagh Group S.A.
• Becton Dickinson and Company
• Berry Global Group Inc.
• Bilcare Limited
• Catalent Inc.
• Clondalkin Group Holdings B.V.
• Constantia Flexibles Group GmbH
• Gerresheimer AG
• Klockner Pentaplast Group
• Mondi Group
• Nipro Corporation
• Piramal Glass Private Limited
• Schott AG
• Sealed Air Corporation
• Uflex Ltd.
• West Pharmaceutical Services Inc.
• Westrock Company
• Wipak Group
• Harpak Ulma
• Bandall Pharma Packaging Solutions
• Nolato AB（publ）
• Medical Packaging Inc. LLC
• Origin Pharma Packaging
• その他

List of Tables

• TABLE 1 Global Pharmaceutical Container Market By Product, 2023-2033, USD (Million)
• TABLE 2 Global Pharmaceutical Container Market By Bottles, 2023-2033, USD (Million)
• TABLE 3 Global Pharmaceutical Container Market By Material Type, 2023-2033, USD (Million)
• TABLE 4 Global Pharmaceutical Container Market By Plastics, 2023-2033, USD (Million)
• TABLE 5 Global Pharmaceutical Container Market By Polyethylene, 2023-2033, USD (Million)
• TABLE 6 North America Pharmaceutical Container Market By Product, 2023-2033, USD (Million)
• TABLE 7 North America Pharmaceutical Container Market By Bottles, 2023-2033, USD (Million)
• TABLE 8 North America Pharmaceutical Container Market By Material Type, 2023-2033, USD (Million)
• TABLE 9 North America Pharmaceutical Container Market By Plastics, 2023-2033, USD (Million)
• TABLE 10 North America Pharmaceutical Container Market By Polyethylene, 2023-2033, USD (Million)
• TABLE 11 U.S. Pharmaceutical Container Market By Product, 2023-2033, USD (Million)
• TABLE 12 U.S. Pharmaceutical Container Market By Bottles, 2023-2033, USD (Million)
• TABLE 13 U.S. Pharmaceutical Container Market By Material Type, 2023-2033, USD (Million)
• TABLE 14 U.S. Pharmaceutical Container Market By Plastics, 2023-2033, USD (Million)
• TABLE 15 U.S. Pharmaceutical Container Market By Polyethylene, 2023-2033, USD (Million)
• TABLE 16 Canada Pharmaceutical Container Market By Product, 2023-2033, USD (Million)
• TABLE 17 Canada Pharmaceutical Container Market By Bottles, 2023-2033, USD (Million)
• TABLE 18 Canada Pharmaceutical Container Market By Material Type, 2023-2033, USD (Million)
• TABLE 19 Canada Pharmaceutical Container Market By Plastics, 2023-2033, USD (Million)
• TABLE 20 Canada Pharmaceutical Container Market By Polyethylene, 2023-2033, USD (Million)
• TABLE 21 Rest of North America Pharmaceutical Container Market By Product, 2023-2033, USD (Million)
• TABLE 22 Rest of North America Pharmaceutical Container Market By Bottles, 2023-2033, USD (Million)
• TABLE 23 Rest of North America Pharmaceutical Container Market By Material Type, 2023-2033, USD (Million)
• TABLE 24 Rest of North America Pharmaceutical Container Market By Plastics, 2023-2033, USD (Million)
• TABLE 25 Rest of North America Pharmaceutical Container Market By Polyethylene, 2023-2033, USD (Million)
• TABLE 26 UK and European Union Pharmaceutical Container Market By Product, 2023-2033, USD (Million)
• TABLE 27 UK and European Union Pharmaceutical Container Market By Bottles, 2023-2033, USD (Million)
• TABLE 28 UK and European Union Pharmaceutical Container Market By Material Type, 2023-2033, USD (Million)
• TABLE 29 UK and European Union Pharmaceutical Container Market By Plastics, 2023-2033, USD (Million)
• TABLE 30 UK and European Union Pharmaceutical Container Market By Polyethylene, 2023-2033, USD (Million)
• TABLE 31 UK Pharmaceutical Container Market By Product, 2023-2033, USD (Million)
• TABLE 32 UK Pharmaceutical Container Market By Bottles, 2023-2033, USD (Million)
• TABLE 33 UK Pharmaceutical Container Market By Material Type, 2023-2033, USD (Million)
• TABLE 34 UK Pharmaceutical Container Market By Plastics, 2023-2033, USD (Million)
• TABLE 35 UK Pharmaceutical Container Market By Polyethylene, 2023-2033, USD (Million)
• TABLE 36 Germany Pharmaceutical Container Market By Product, 2023-2033, USD (Million)
• TABLE 37 Germany Pharmaceutical Container Market By Bottles, 2023-2033, USD (Million)
• TABLE 38 Germany Pharmaceutical Container Market By Material Type, 2023-2033, USD (Million)
• TABLE 39 Germany Pharmaceutical Container Market By Plastics, 2023-2033, USD (Million)
• TABLE 40 Germany Pharmaceutical Container Market By Polyethylene, 2023-2033, USD (Million)
• TABLE 41 Spain Pharmaceutical Container Market By Product, 2023-2033, USD (Million)
• TABLE 42 Spain Pharmaceutical Container Market By Bottles, 2023-2033, USD (Million)
• TABLE 43 Spain Pharmaceutical Container Market By Material Type, 2023-2033, USD (Million)
• TABLE 44 Spain Pharmaceutical Container Market By Plastics, 2023-2033, USD (Million)
• TABLE 45 Spain Pharmaceutical Container Market By Polyethylene, 2023-2033, USD (Million)
• TABLE 46 Italy Pharmaceutical Container Market By Product, 2023-2033, USD (Million)
• TABLE 47 Italy Pharmaceutical Container Market By Bottles, 2023-2033, USD (Million)
• TABLE 48 Italy Pharmaceutical Container Market By Material Type, 2023-2033, USD (Million)
• TABLE 49 Italy Pharmaceutical Container Market By Plastics, 2023-2033, USD (Million)
• TABLE 50 Italy Pharmaceutical Container Market By Polyethylene, 2023-2033, USD (Million)
• TABLE 51 France Pharmaceutical Container Market By Product, 2023-2033, USD (Million)
• TABLE 52 France Pharmaceutical Container Market By Bottles, 2023-2033, USD (Million)
• TABLE 53 France Pharmaceutical Container Market By Material Type, 2023-2033, USD (Million)
• TABLE 54 France Pharmaceutical Container Market By Plastics, 2023-2033, USD (Million)
• TABLE 55 France Pharmaceutical Container Market By Polyethylene, 2023-2033, USD (Million)
• TABLE 56 Rest of Europe Pharmaceutical Container Market By Product, 2023-2033, USD (Million)
• TABLE 57 Rest of Europe Pharmaceutical Container Market By Bottles, 2023-2033, USD (Million)
• TABLE 58 Rest of Europe Pharmaceutical Container Market By Material Type, 2023-2033, USD (Million)
• TABLE 59 Rest of Europe Pharmaceutical Container Market By Plastics, 2023-2033, USD (Million)
• TABLE 60 Rest of Europe Pharmaceutical Container Market By Polyethylene, 2023-2033, USD (Million)
• TABLE 61 Asia Pharmaceutical Container Market By Product, 2023-2033, USD (Million)
• TABLE 62 Asia Pharmaceutical Container Market By Bottles, 2023-2033, USD (Million)
• TABLE 63 Asia Pharmaceutical Container Market By Material Type, 2023-2033, USD (Million)
• TABLE 64 Asia Pharmaceutical Container Market By Plastics, 2023-2033, USD (Million)
• TABLE 65 Asia Pharmaceutical Container Market By Polyethylene, 2023-2033, USD (Million)
• TABLE 66 China Pharmaceutical Container Market By Product, 2023-2033, USD (Million)
• TABLE 67 China Pharmaceutical Container Market By Bottles, 2023-2033, USD (Million)
• TABLE 68 China Pharmaceutical Container Market By Material Type, 2023-2033, USD (Million)
• TABLE 69 China Pharmaceutical Container Market By Plastics, 2023-2033, USD (Million)
• TABLE 70 China Pharmaceutical Container Market By Polyethylene, 2023-2033, USD (Million)
• TABLE 71 Japan Pharmaceutical Container Market By Product, 2023-2033, USD (Million)
• TABLE 72 Japan Pharmaceutical Container Market By Bottles, 2023-2033, USD (Million)
• TABLE 73 Japan Pharmaceutical Container Market By Material Type, 2023-2033, USD (Million)
• TABLE 74 Japan Pharmaceutical Container Market By Plastics, 2023-2033, USD (Million)
• TABLE 75 Japan Pharmaceutical Container Market By Polyethylene, 2023-2033, USD (Million)
• TABLE 76 India Pharmaceutical Container Market By Product, 2023-2033, USD (Million)
• TABLE 77 India Pharmaceutical Container Market By Bottles, 2023-2033, USD (Million)
• TABLE 78 India Pharmaceutical Container Market By Material Type, 2023-2033, USD (Million)
• TABLE 79 India Pharmaceutical Container Market By Plastics, 2023-2033, USD (Million)
• TABLE 80 India Pharmaceutical Container Market By Polyethylene, 2023-2033, USD (Million)
• TABLE 81 Australia Pharmaceutical Container Market By Product, 2023-2033, USD (Million)
• TABLE 82 Australia Pharmaceutical Container Market By Bottles, 2023-2033, USD (Million)
• TABLE 83 Australia Pharmaceutical Container Market By Material Type, 2023-2033, USD (Million)
• TABLE 84 Australia Pharmaceutical Container Market By Plastics, 2023-2033, USD (Million)
• TABLE 85 Australia Pharmaceutical Container Market By Polyethylene, 2023-2033, USD (Million)
• TABLE 86 South Korea Pharmaceutical Container Market By Product, 2023-2033, USD (Million)
• TABLE 87 South Korea Pharmaceutical Container Market By Bottles, 2023-2033, USD (Million)
• TABLE 88 South Korea Pharmaceutical Container Market By Material Type, 2023-2033, USD (Million)
• TABLE 89 South Korea Pharmaceutical Container Market By Plastics, 2023-2033, USD (Million)
• TABLE 90 South Korea Pharmaceutical Container Market By Polyethylene, 2023-2033, USD (Million)
• TABLE 91 Latin America Pharmaceutical Container Market By Product, 2023-2033, USD (Million)
• TABLE 92 Latin America Pharmaceutical Container Market By Bottles, 2023-2033, USD (Million)
• TABLE 93 Latin America Pharmaceutical Container Market By Material Type, 2023-2033, USD (Million)
• TABLE 94 Latin America Pharmaceutical Container Market By Plastics, 2023-2033, USD (Million)
• TABLE 95 Latin America Pharmaceutical Container Market By Polyethylene, 2023-2033, USD (Million)
• TABLE 96 Brazil Pharmaceutical Container Market By Product, 2023-2033, USD (Million)
• TABLE 97 Brazil Pharmaceutical Container Market By Bottles, 2023-2033, USD (Million)
• TABLE 98 Brazil Pharmaceutical Container Market By Material Type, 2023-2033, USD (Million)
• TABLE 99 Brazil Pharmaceutical Container Market By Plastics, 2023-2033, USD (Million)
• TABLE 100 Brazil Pharmaceutical Container Market By Polyethylene, 2023-2033, USD (Million)
• TABLE 101 Mexico Pharmaceutical Container Market By Product, 2023-2033, USD (Million)
• TABLE 102 Mexico Pharmaceutical Container Market By Bottles, 2023-2033, USD (Million)
• TABLE 103 Mexico Pharmaceutical Container Market By Material Type, 2023-2033, USD (Million)
• TABLE 104 Mexico Pharmaceutical Container Market By Plastics, 2023-2033, USD (Million)
• TABLE 105 Mexico Pharmaceutical Container Market By Polyethylene, 2023-2033, USD (Million)
• TABLE 106 Rest of Latin America Pharmaceutical Container Market By Product, 2023-2033, USD (Million)
• TABLE 107 Rest of Latin America Pharmaceutical Container Market By Bottles, 2023-2033, USD (Million)
• TABLE 108 Rest of Latin America Pharmaceutical Container Market By Material Type, 2023-2033, USD (Million)
• TABLE 109 Rest of Latin America Pharmaceutical Container Market By Plastics, 2023-2033, USD (Million)
• TABLE 110 Rest of Latin America Pharmaceutical Container Market By Polyethylene, 2023-2033, USD (Million)
• TABLE 111 Middle East and Africa Pharmaceutical Container Market By Product, 2023-2033, USD (Million)
• TABLE 112 Middle East and Africa Pharmaceutical Container Market By Bottles, 2023-2033, USD (Million)
• TABLE 113 Middle East and Africa Pharmaceutical Container Market By Material Type, 2023-2033, USD (Million)
• TABLE 114 Middle East and Africa Pharmaceutical Container Market By Plastics, 2023-2033, USD (Million)
• TABLE 115 Middle East and Africa Pharmaceutical Container Market By Polyethylene, 2023-2033, USD (Million)
• TABLE 116 GCC Pharmaceutical Container Market By Product, 2023-2033, USD (Million)
• TABLE 117 GCC Pharmaceutical Container Market By Bottles, 2023-2033, USD (Million)
• TABLE 118 GCC Pharmaceutical Container Market By Material Type, 2023-2033, USD (Million)
• TABLE 119 GCC Pharmaceutical Container Market By Plastics, 2023-2033, USD (Million)
• TABLE 120 GCC Pharmaceutical Container Market By Polyethylene, 2023-2033, USD (Million)
• TABLE 121 Africa Pharmaceutical Container Market By Product, 2023-2033, USD (Million)
• TABLE 122 Africa Pharmaceutical Container Market By Bottles, 2023-2033, USD (Million)
• TABLE 123 Africa Pharmaceutical Container Market By Material Type, 2023-2033, USD (Million)
• TABLE 124 Africa Pharmaceutical Container Market By Plastics, 2023-2033, USD (Million)
• TABLE 125 Africa Pharmaceutical Container Market By Polyethylene, 2023-2033, USD (Million)
• TABLE 126 Rest of Middle East and Africa Pharmaceutical Container Market By Product, 2023-2033, USD (Million)
• TABLE 127 Rest of Middle East and Africa Pharmaceutical Container Market By Bottles, 2023-2033, USD (Million)
• TABLE 128 Rest of Middle East and Africa Pharmaceutical Container Market By Material Type, 2023-2033, USD (Million)
• TABLE 129 Rest of Middle East and Africa Pharmaceutical Container Market By Plastics, 2023-2033, USD (Million)
• TABLE 130 Rest of Middle East and Africa Pharmaceutical Container Market By Polyethylene, 2023-2033, USD (Million)

List of Figures

• FIG. 1 Global Pharmaceutical Container Market: Market Coverage
• FIG. 2 Research Methodology and Data Sources
• FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
• FIG. 4 Global Pharmaceutical Container Market: Quality Assurance
• FIG. 5 Global Pharmaceutical Container Market, By Product, 2024
• FIG. 6 Global Pharmaceutical Container Market, By Material Type, 2024
• FIG. 7 Global Pharmaceutical Container Market, By Geography, 2024
• FIG. 8 Market Geographical Opportunity Matrix - Global Pharmaceutical Container Market, 2024
• FIG. 9Market Positioning of Key Pharmaceutical Container Market Players, 2024
• FIG. 10 Global Pharmaceutical Container Market, By Product, 2024 Vs 2033, %
• FIG. 11 Global Pharmaceutical Container Market, By Material Type, 2024 Vs 2033, %

The pharmaceutical container market encapsulates the array of packaging mechanisms utilized for pharmaceutical products. These containers are vital, ensuring the protection of the medication or other products from external variables, such as moisture, light, and oxygen, thereby preserving their efficacy and extending shelf life. With the pharmaceutical industry's burgeoning growth, the market for its containers has expanded congruently. In 2024, a myriad of factors influenced this market, from driving forces to challenges that impeded growth. Pharmaceutical container market is estimated to grow at a CAGR of 6.0% from 2025 to 2033.

Driver: Increased Global Demand for Pharmaceuticals

The last two decades saw an upsurge in chronic diseases, ranging from diabetes to cardiovascular diseases. For instance, the World Health Organization (no research company evidence) pointed out that chronic diseases are responsible for approximately 60% of all deaths globally. This surge naturally translated to a higher demand for medication, and consequently, the containers to store them. Moreover, emerging health challenges, like the COVID-19 pandemic, accentuated this demand. The rapid development, production, and global distribution of vaccines and antiviral medications necessitated a massive quantity of pharmaceutical containers. In turn, manufacturers had to scale up production to meet the global requirements for vials, ampoules, and other specialized containers.

Opportunity: Advent of Biodegradable and Sustainable Packaging

With sustainability becoming a global concern, industries across the board are transitioning to eco-friendly solutions. The pharmaceutical container segment isn't immune to this shift. Companies have started experimenting with and producing biodegradable containers, especially given the global outcry against plastic pollution. A study published in the journal "Science Advances" (no research company evidence) highlighted that only 9% of the world's plastic is recycled. This data underscored the imperative need for sustainable alternatives, prompting pharmaceutical container manufacturers to innovate. The new containers, made from materials like plant-based plastics or other biodegradable components, not only cater to the environmental cause but also offer benefits like reduced carbon footprint in their production process. This transition presents a lucrative opportunity for players in the market to cater to the dual demand of pharmaceutical containment and environmental sustainability.

Restraint: Stringent Regulatory Compliance

The pharmaceutical industry, given its direct implications on public health, is stringently regulated. The same extends to its containers. Regulatory bodies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have outlined clear, often rigorous, standards that these containers must meet. These regulations ascertain that containers do not interact with the drugs they store, potentially altering the drug's properties and compromising patient safety. While these standards are indisputably necessary, they pose challenges. Manufacturers often find themselves investing significantly in ensuring their containers are compliant, which can drive up costs. Additionally, any non-compliance can result in recalls, a scenario pharma companies dread given the financial and reputational implications.

Challenge: Counterfeit Pharmaceutical Packaging

As with any profitable market, the pharmaceutical container segment grapples with the menace of counterfeits. Fake medications are a global problem, with counterfeiters often using packaging so similar to the original that distinguishing between the two becomes arduous. The World Health Organization, in its report, stated that up to 10% of drugs worldwide could be counterfeit, posing severe health risks. For pharmaceutical container manufacturers, this trend is worrisome. Not only do they face losses due to these counterfeit products, but the presence of fake drugs also erodes trust in their brands. Combatting this requires additional investments in security features, like tamper-evident seals or unique identifiers, further escalating costs.

Product Insights

Bottles have historically dominated this market due to their ubiquity and convenience. They held the highest revenue generation slot in 2024, with a substantial market share. Their wide application, ranging from over-the-counter liquid medicines to a myriad of prescription drugs, underscored their dominance. Following closely, Blisters showed an impressive uptick. Essential for unit dose packaging and offering enhanced protection against moisture, they have become a favorite for many pharmaceutical companies. But, when it came to the highest CAGR, Prefilled Syringes & Cartridges took the crown. Their growth is attributed to the increasing demand for vaccines and biologics. The ease of administration, reduced wastage, and the ability to maintain sterility make them a preferred choice for new drug delivery. The other products, like Vials & Ampoules, Bags & Pouches, Sachets, and Tubes, also had their significant market shares and are expected to grow at varied rates over the forecast period.

Material Type Insights

Plastics, due to their versatility and cost-effectiveness, generated the highest revenue in 2024. Their ability to be molded into various forms, combined with their lightweight nature, made them a popular choice for pharmaceutical containers. Glass, known for its impermeability and transparency, trailed behind plastics in revenue but is often preferred for specific medications due to its inert nature. Interestingly, Metals, especially in the form of aluminum blister packs or certain ointment tubes, showed the highest CAGR. Their growth can be linked to their ability to provide an excellent barrier against light, moisture, and oxygen. Meanwhile, Paper, primarily used in secondary packaging, contributed to the market but remained niche compared to the former materials.

Regional Insights

North America, driven by the United States' vast pharmaceutical industry, accounted for the highest revenue percent in 2024. The region's robust healthcare infrastructure, combined with significant pharmaceutical innovations, propelled it to the forefront. However, Asia-Pacific, with countries like India and China, is expected to witness the highest CAGR from 2025 to 2033. The reasons being increased pharmaceutical production, favorable government policies, and a growing healthcare awareness among the vast population.

Competitive Trends

The pharmaceutical container market landscape was dotted with several prominent players in 2024. Companies like Amcor Plc, Ardagh Group S.A., Becton, Dickinson and Company, Berry Global Group, Inc., Bilcare Limited, Catalent, Inc., Clondalkin Group Holdings B.V., Constantia Flexibles Group GmbH, Gerresheimer AG, Klockner Pentaplast Group, Mondi Group, Nipro Corporation, Piramal Glass Private Limited, Schott AG, Sealed Air Corporation , Uflex Ltd., West Pharmaceutical Services, Inc., Westrock Company, Wipak Group, Harpak Ulma, Bandall Pharma Packaging Solutions, Nolato AB (publ), Medical Packaging Inc., LLC, Origin Pharma Packaging led in revenue generation, focusing on innovations and sustainable solutions. Their strategies often revolved around mergers and acquisitions, production capacity expansions, and launching novel, patient-friendly packaging solutions. As sustainability became a global watchword, many of these companies shifted towards eco-friendly packaging options. Innovations such as tamper-evident seals, smart packaging solutions with RFID chips, and adherence monitoring features are expected to be the focal points in the strategies of these market players in the forecast period. As 2025 dawns, the anticipation is for a more competitive, innovation-driven market, with players vying for the top spot by leveraging technology and sustainability.

Historical & Forecast Period

This study report represents an analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Pharmaceutical Container market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users & consumption volume, price, and value.

Geographical revenues generated by countries considered in the report

Micro and macro environment factors that are currently influencing the Pharmaceutical Container market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

• Market Segmentation
• Product
• Bottles
• Packer Bottles
• Liquid Bottles
  • Vials & Ampoules
  • Blisters
  • Bags & Pouches
  • Prefilled Syringes & Cartridges
  • Sachets
  • Trays
  • Tubes
  • Containers, Jars, & Others
• Material Type
• Plastics
• Polyethylene
• LDPE
• HDPE
• Polyvinyl Chloride
• Polypropylene
• Polystyrene
• Polyethylene Terephthalate
• Others (Polycarbonate)
  • Glass
  • Metals
  • Paper
• Region Segment (2023-2033; US$ Million)
• North America
• U.S.
• Canada
• Rest of North America
• UK and European Union
• UK
• Germany
• Spain
• Italy
• France
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East and Africa
• GCC
• Africa
• Rest of Middle East and Africa

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Pharmaceutical Container market?
• What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2033.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Pharmaceutical Container market?
• Which is the largest regional market for Pharmaceutical Container market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Pharmaceutical Container market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Pharmaceutical Container market worldwide?

Table of Contents

1. Preface

• 1.1. Report Description
  • 1.1.1. Purpose of the Report
  • 1.1.2. Target Audience
  • 1.1.3. Key Offerings
• 1.2. Market Segmentation
• 1.3. Research Methodology
  • 1.3.1. Phase I - Secondary Research
  • 1.3.2. Phase II - Primary Research
  • 1.3.3. Phase III - Expert Panel Review
  • 1.3.4. Assumptions
  • 1.3.5. Approach Adopted

2. Executive Summary

• 2.1. Market Snapshot: Global Pharmaceutical Container Market
• 2.2. Global Pharmaceutical Container Market, By Product, 2024 (US$ Million)
• 2.3. Global Pharmaceutical Container Market, By Material Type, 2024 (US$ Million)
• 2.4. Global Pharmaceutical Container Market, By Geography, 2024 (US$ Million)
• 2.5. Attractive Investment Proposition by Geography, 2024

3. Pharmaceutical Container Market: Competitive Analysis

• 3.1. Market Positioning of Key Pharmaceutical Container Market Vendors
• 3.2. Strategies Adopted by Pharmaceutical Container Market Vendors
• 3.3. Key Industry Strategies

4. Pharmaceutical Container Market: Macro Analysis & Market Dynamics

• 4.1. Introduction
• 4.2. Global Pharmaceutical Container Market Value, 2023 - 2033, (US$ Million)
• 4.3. Market Dynamics
  • 4.3.1. Market Drivers
  • 4.3.2. Market Restraints
  • 4.3.3. Key Challenges
  • 4.3.4. Key Opportunities
• 4.4. Impact Analysis of Drivers and Restraints
• 4.5. See-Saw Analysis
• 4.6. Porter's Five Force Model
  • 4.6.1. Supplier Power
  • 4.6.2. Buyer Power
  • 4.6.3. Threat Of Substitutes
  • 4.6.4. Threat Of New Entrants
  • 4.6.5. Competitive Rivalry
• 4.7. PESTEL Analysis
  • 4.7.1. Political Landscape
  • 4.7.2. Economic Landscape
  • 4.7.3. Technology Landscape
  • 4.7.4. Legal Landscape
  • 4.7.5. Social Landscape

5. Pharmaceutical Container Market: By Product, 2023-2033, USD (Million)

• 5.1. Market Overview
• 5.2. Growth & Revenue Analysis: 2024 Versus 2033
• 5.3. Market Segmentation
  • 5.3.1. Bottles
    • 5.3.1.1. Packer Bottles
    • 5.3.1.2. Liquid Bottles
  • 5.3.2. Vials & Ampoules
  • 5.3.3. Blisters
  • 5.3.4. Bags & Pouches
  • 5.3.5. Prefilled Syringes & Cartridges
  • 5.3.6. Sachets
  • 5.3.7. Trays
  • 5.3.8. Tubes
  • 5.3.9. Containers, Jars, & Others

6. Pharmaceutical Container Market: By Material Type, 2023-2033, USD (Million)

• 6.1. Market Overview
• 6.2. Growth & Revenue Analysis: 2024 Versus 2033
• 6.3. Market Segmentation
  • 6.3.1. Plastics
    • 6.3.1.1. Polyethylene
      • 6.3.1.1.1. LDPE
      • 6.3.1.1.2. HDPE
    • 6.3.1.2. Polyvinyl Chloride
    • 6.3.1.3. Polypropylene
    • 6.3.1.4. Polystyrene
    • 6.3.1.5. Polyethylene Terephthalate
    • 6.3.1.6. Others (Polycarbonate)
  • 6.3.2. Glass
  • 6.3.3. Metals
  • 6.3.4. Paper

7. North America Pharmaceutical Container Market, 2023-2033, USD (Million)

• 7.1. Market Overview
• 7.2. Pharmaceutical Container Market: By Product, 2023-2033, USD (Million)
• 7.3. Pharmaceutical Container Market: By Material Type, 2023-2033, USD (Million)
• 7.4.Pharmaceutical Container Market: By Region, 2023-2033, USD (Million)
  • 7.4.1.North America
    • 7.4.1.1. U.S.
      • 7.4.1.1.1. Pharmaceutical Container Market: By Product, 2023-2033, USD (Million)
      • 7.4.1.1.2. Pharmaceutical Container Market: By Material Type, 2023-2033, USD (Million)
    • 7.4.1.2. Canada
      • 7.4.1.2.1. Pharmaceutical Container Market: By Product, 2023-2033, USD (Million)
      • 7.4.1.2.2. Pharmaceutical Container Market: By Material Type, 2023-2033, USD (Million)
    • 7.4.1.3. Rest of North America
      • 7.4.1.3.1. Pharmaceutical Container Market: By Product, 2023-2033, USD (Million)
      • 7.4.1.3.2. Pharmaceutical Container Market: By Material Type, 2023-2033, USD (Million)

8. UK and European Union Pharmaceutical Container Market, 2023-2033, USD (Million)

• 8.1. Market Overview
• 8.2. Pharmaceutical Container Market: By Product, 2023-2033, USD (Million)
• 8.3. Pharmaceutical Container Market: By Material Type, 2023-2033, USD (Million)
• 8.4.Pharmaceutical Container Market: By Region, 2023-2033, USD (Million)
  • 8.4.1.UK and European Union
    • 8.4.1.1. UK
      • 8.4.1.1.1. Pharmaceutical Container Market: By Product, 2023-2033, USD (Million)
      • 8.4.1.1.2. Pharmaceutical Container Market: By Material Type, 2023-2033, USD (Million)
    • 8.4.1.2. Germany
      • 8.4.1.2.1. Pharmaceutical Container Market: By Product, 2023-2033, USD (Million)
      • 8.4.1.2.2. Pharmaceutical Container Market: By Material Type, 2023-2033, USD (Million)
    • 8.4.1.3. Spain
      • 8.4.1.3.1. Pharmaceutical Container Market: By Product, 2023-2033, USD (Million)
      • 8.4.1.3.2. Pharmaceutical Container Market: By Material Type, 2023-2033, USD (Million)
    • 8.4.1.4. Italy
      • 8.4.1.4.1. Pharmaceutical Container Market: By Product, 2023-2033, USD (Million)
      • 8.4.1.4.2. Pharmaceutical Container Market: By Material Type, 2023-2033, USD (Million)
    • 8.4.1.5. France
      • 8.4.1.5.1. Pharmaceutical Container Market: By Product, 2023-2033, USD (Million)
      • 8.4.1.5.2. Pharmaceutical Container Market: By Material Type, 2023-2033, USD (Million)
    • 8.4.1.6. Rest of Europe
      • 8.4.1.6.1. Pharmaceutical Container Market: By Product, 2023-2033, USD (Million)
      • 8.4.1.6.2. Pharmaceutical Container Market: By Material Type, 2023-2033, USD (Million)

9. Asia Pacific Pharmaceutical Container Market, 2023-2033, USD (Million)

• 9.1. Market Overview
• 9.2. Pharmaceutical Container Market: By Product, 2023-2033, USD (Million)
• 9.3. Pharmaceutical Container Market: By Material Type, 2023-2033, USD (Million)
• 9.4.Pharmaceutical Container Market: By Region, 2023-2033, USD (Million)
  • 9.4.1.Asia Pacific
    • 9.4.1.1. China
      • 9.4.1.1.1. Pharmaceutical Container Market: By Product, 2023-2033, USD (Million)
      • 9.4.1.1.2. Pharmaceutical Container Market: By Material Type, 2023-2033, USD (Million)
    • 9.4.1.2. Japan
      • 9.4.1.2.1. Pharmaceutical Container Market: By Product, 2023-2033, USD (Million)
      • 9.4.1.2.2. Pharmaceutical Container Market: By Material Type, 2023-2033, USD (Million)
    • 9.4.1.3. India
      • 9.4.1.3.1. Pharmaceutical Container Market: By Product, 2023-2033, USD (Million)
      • 9.4.1.3.2. Pharmaceutical Container Market: By Material Type, 2023-2033, USD (Million)
    • 9.4.1.4. Australia
      • 9.4.1.4.1. Pharmaceutical Container Market: By Product, 2023-2033, USD (Million)
      • 9.4.1.4.2. Pharmaceutical Container Market: By Material Type, 2023-2033, USD (Million)
    • 9.4.1.5. South Korea
      • 9.4.1.5.1. Pharmaceutical Container Market: By Product, 2023-2033, USD (Million)
      • 9.4.1.5.2. Pharmaceutical Container Market: By Material Type, 2023-2033, USD (Million)
    • 9.4.1.6. Rest of Asia Pacific
      • 9.4.1.6.1. Pharmaceutical Container Market: By Product, 2023-2033, USD (Million)
      • 9.4.1.6.2. Pharmaceutical Container Market: By Material Type, 2023-2033, USD (Million)

10. Latin America Pharmaceutical Container Market, 2023-2033, USD (Million)

• 10.1. Market Overview
• 10.2. Pharmaceutical Container Market: By Product, 2023-2033, USD (Million)
• 10.3. Pharmaceutical Container Market: By Material Type, 2023-2033, USD (Million)
• 10.4.Pharmaceutical Container Market: By Region, 2023-2033, USD (Million)
  • 10.4.1.Latin America
    • 10.4.1.1. Brazil
      • 10.4.1.1.1. Pharmaceutical Container Market: By Product, 2023-2033, USD (Million)
      • 10.4.1.1.2. Pharmaceutical Container Market: By Material Type, 2023-2033, USD (Million)
    • 10.4.1.2. Mexico
      • 10.4.1.2.1. Pharmaceutical Container Market: By Product, 2023-2033, USD (Million)
      • 10.4.1.2.2. Pharmaceutical Container Market: By Material Type, 2023-2033, USD (Million)
    • 10.4.1.3. Rest of Latin America
      • 10.4.1.3.1. Pharmaceutical Container Market: By Product, 2023-2033, USD (Million)
      • 10.4.1.3.2. Pharmaceutical Container Market: By Material Type, 2023-2033, USD (Million)

11. Middle East and Africa Pharmaceutical Container Market, 2023-2033, USD (Million)

• 11.1. Market Overview
• 11.2. Pharmaceutical Container Market: By Product, 2023-2033, USD (Million)
• 11.3. Pharmaceutical Container Market: By Material Type, 2023-2033, USD (Million)
• 11.4.Pharmaceutical Container Market: By Region, 2023-2033, USD (Million)
  • 11.4.1.Middle East and Africa
    • 11.4.1.1. GCC
      • 11.4.1.1.1. Pharmaceutical Container Market: By Product, 2023-2033, USD (Million)
      • 11.4.1.1.2. Pharmaceutical Container Market: By Material Type, 2023-2033, USD (Million)
    • 11.4.1.2. Africa
      • 11.4.1.2.1. Pharmaceutical Container Market: By Product, 2023-2033, USD (Million)
      • 11.4.1.2.2. Pharmaceutical Container Market: By Material Type, 2023-2033, USD (Million)
    • 11.4.1.3. Rest of Middle East and Africa
      • 11.4.1.3.1. Pharmaceutical Container Market: By Product, 2023-2033, USD (Million)
      • 11.4.1.3.2. Pharmaceutical Container Market: By Material Type, 2023-2033, USD (Million)

12. Company Profile

• 12.1. Amcor Plc
  • 12.1.1. Company Overview
  • 12.1.2. Financial Performance
  • 12.1.3. Product Portfolio
  • 12.1.4. Strategic Initiatives
• 12.2. Ardagh Group S.A.
  • 12.2.1. Company Overview
  • 12.2.2. Financial Performance
  • 12.2.3. Product Portfolio
  • 12.2.4. Strategic Initiatives
• 12.3. Becton, Dickinson and Company
  • 12.3.1. Company Overview
  • 12.3.2. Financial Performance
  • 12.3.3. Product Portfolio
  • 12.3.4. Strategic Initiatives
• 12.4. Berry Global Group, Inc.
  • 12.4.1. Company Overview
  • 12.4.2. Financial Performance
  • 12.4.3. Product Portfolio
  • 12.4.4. Strategic Initiatives
• 12.5. Bilcare Limited
  • 12.5.1. Company Overview
  • 12.5.2. Financial Performance
  • 12.5.3. Product Portfolio
  • 12.5.4. Strategic Initiatives
• 12.6. Catalent, Inc.
  • 12.6.1. Company Overview
  • 12.6.2. Financial Performance
  • 12.6.3. Product Portfolio
  • 12.6.4. Strategic Initiatives
• 12.7. Clondalkin Group Holdings B.V.
  • 12.7.1. Company Overview
  • 12.7.2. Financial Performance
  • 12.7.3. Product Portfolio
  • 12.7.4. Strategic Initiatives
• 12.8. Constantia Flexibles Group GmbH
  • 12.8.1. Company Overview
  • 12.8.2. Financial Performance
  • 12.8.3. Product Portfolio
  • 12.8.4. Strategic Initiatives
• 12.9. Gerresheimer AG
  • 12.9.1. Company Overview
  • 12.9.2. Financial Performance
  • 12.9.3. Product Portfolio
  • 12.9.4. Strategic Initiatives
• 12.10. Klockner Pentaplast Group
  • 12.10.1. Company Overview
  • 12.10.2. Financial Performance
  • 12.10.3. Product Portfolio
  • 12.10.4. Strategic Initiatives
• 12.11. Mondi Group
  • 12.11.1. Company Overview
  • 12.11.2. Financial Performance
  • 12.11.3. Product Portfolio
  • 12.11.4. Strategic Initiatives
• 12.12. Nipro Corporation
  • 12.12.1. Company Overview
  • 12.12.2. Financial Performance
  • 12.12.3. Product Portfolio
  • 12.12.4. Strategic Initiatives
• 12.13. Piramal Glass Private Limited
  • 12.13.1. Company Overview
  • 12.13.2. Financial Performance
  • 12.13.3. Product Portfolio
  • 12.13.4. Strategic Initiatives
• 12.14. Schott AG
  • 12.14.1. Company Overview
  • 12.14.2. Financial Performance
  • 12.14.3. Product Portfolio
  • 12.14.4. Strategic Initiatives
• 12.15. Sealed Air Corporation
  • 12.15.1. Company Overview
  • 12.15.2. Financial Performance
  • 12.15.3. Product Portfolio
  • 12.15.4. Strategic Initiatives
• 12.16. Uflex Ltd.
  • 12.16.1. Company Overview
  • 12.16.2. Financial Performance
  • 12.16.3. Product Portfolio
  • 12.16.4. Strategic Initiatives
• 12.17. West Pharmaceutical Services, Inc.
  • 12.17.1. Company Overview
  • 12.17.2. Financial Performance
  • 12.17.3. Product Portfolio
  • 12.17.4. Strategic Initiatives
• 12.18. Westrock Company
  • 12.18.1. Company Overview
  • 12.18.2. Financial Performance
  • 12.18.3. Product Portfolio
  • 12.18.4. Strategic Initiatives
• 12.19. Wipak Group
  • 12.19.1. Company Overview
  • 12.19.2. Financial Performance
  • 12.19.3. Product Portfolio
  • 12.19.4. Strategic Initiatives
• 12.20. Harpak Ulma
  • 12.20.1. Company Overview
  • 12.20.2. Financial Performance
  • 12.20.3. Product Portfolio
  • 12.20.4. Strategic Initiatives
• 12.21. Bandall Pharma Packaging Solutions
  • 12.21.1. Company Overview
  • 12.21.2. Financial Performance
  • 12.21.3. Product Portfolio
  • 12.21.4. Strategic Initiatives
• 12.22. Nolato AB (publ)
  • 12.22.1. Company Overview
  • 12.22.2. Financial Performance
  • 12.22.3. Product Portfolio
  • 12.22.4. Strategic Initiatives
• 12.23. Medical Packaging Inc., LLC
  • 12.23.1. Company Overview
  • 12.23.2. Financial Performance
  • 12.23.3. Product Portfolio
  • 12.23.4. Strategic Initiatives
• 12.24. Origin Pharma Packaging
  • 12.24.1. Company Overview
  • 12.24.2. Financial Performance
  • 12.24.3. Product Portfolio
  • 12.24.4. Strategic Initiatives
• 12.25. Others
  • 12.25.1. Company Overview
  • 12.25.2. Financial Performance
  • 12.25.3. Product Portfolio
  • 12.25.4. Strategic Initiatives